Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng Ju

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Bioorganic & Medicinal Chemistry|August 3, 2010
Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitorsIou-Jiun Kang, Li-Wen Wang, Teng-Kuang Yeh, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2009
Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitorsIou-Jiun Kang, Li-Wen Wang, Sheng-Ju Hsu, et al.
Neural Regeneration Research|February 10, 2022
Transcranial focused ultrasound stimulation reduces vasogenic edema after middle cerebral artery occlusion in miceLi-Dong Deng, Lin Qi, Qian Suo, et al.
Clinical and Translational Medicine|November 21, 2025
Organoid-based two-step drug screening for rapid identification of chemotherapy-resistant oesophageal squamous cell carcinoma and alternative therapiesChen-Ye Shao, Sheng Ju, Xin Tong, et al.
Cancer|April 25, 2023
Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non-small cell lung cancerSheng Ju, Zihan Cui, Yuanyuan Hong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 5, 2024
Efficient Predictor for Immunotherapy Efficacy: Detecting Pan-Clones Effector Tumor Antigen-Specific T Cells in Blood by Nanoparticles Loading Whole Tumor AntigensWeibiao Zeng, Jin Wang, Zhike Chen, et al.
Frontiers in Genetics|June 1, 2022
The Mutation Analysis of the AMT Gene in a Chinese Family With Nonketotic HyperglycinemiaBing-Bo Zhou, Ling Hui, Qing-Hua Zhang, et al.
European Journal of Medicinal Chemistry|February 18, 2019
A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virusTeng-Kuang Yeh, Iou-Jiun Kang, Tsu-An Hsu, et al.
Journal of Medicinal Chemistry|December 15, 2016
A Potent, Selective, and Orally Bioavailable HCV NS5A Inhibitor for Treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazol-2-yl)pyrrolidine-2-carboxamideIou-Jiun Kang, Sheng-Ju Hsu, Hui-Yun Yang, et al.
Scientific Reports|September 11, 2013
Oxygen-vacancy-induced antiferromagnetism to ferromagnetism transformation in Eu₀.₅Ba₀.₅TiO₃₋δ multiferroic thin filmsWeiwei Li, Run Zhao, Le Wang, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry|August 3, 2010
Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitorsIou-Jiun Kang, Li-Wen Wang, Teng-Kuang Yeh, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2009
Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitorsIou-Jiun Kang, Li-Wen Wang, Sheng-Ju Hsu, et al.
Neural Regeneration Research|February 10, 2022
Transcranial focused ultrasound stimulation reduces vasogenic edema after middle cerebral artery occlusion in miceLi-Dong Deng, Lin Qi, Qian Suo, et al.
Clinical and Translational Medicine|November 21, 2025
Organoid-based two-step drug screening for rapid identification of chemotherapy-resistant oesophageal squamous cell carcinoma and alternative therapiesChen-Ye Shao, Sheng Ju, Xin Tong, et al.
Cancer|April 25, 2023
Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non-small cell lung cancerSheng Ju, Zihan Cui, Yuanyuan Hong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 5, 2024
Efficient Predictor for Immunotherapy Efficacy: Detecting Pan-Clones Effector Tumor Antigen-Specific T Cells in Blood by Nanoparticles Loading Whole Tumor AntigensWeibiao Zeng, Jin Wang, Zhike Chen, et al.
Frontiers in Genetics|June 1, 2022
The Mutation Analysis of the AMT Gene in a Chinese Family With Nonketotic HyperglycinemiaBing-Bo Zhou, Ling Hui, Qing-Hua Zhang, et al.
European Journal of Medicinal Chemistry|February 18, 2019
A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virusTeng-Kuang Yeh, Iou-Jiun Kang, Tsu-An Hsu, et al.
Journal of Medicinal Chemistry|December 15, 2016
A Potent, Selective, and Orally Bioavailable HCV NS5A Inhibitor for Treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazol-2-yl)pyrrolidine-2-carboxamideIou-Jiun Kang, Sheng-Ju Hsu, Hui-Yun Yang, et al.
Scientific Reports|September 11, 2013
Oxygen-vacancy-induced antiferromagnetism to ferromagnetism transformation in Eu₀.₅Ba₀.₅TiO₃₋δ multiferroic thin filmsWeiwei Li, Run Zhao, Le Wang, et al.
Pageof 12